Caloric restriction leading to attenuation of experimental Alzheimer's disease results from alterations in gut microbiome
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14823 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Junyu Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Caloric Restriction, Alzheimer Disease, Mice, Transgenic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, The Key Project of Basic Research of Shenzhen.
Themen: Demenz
Abstract (Originalsprache)
Background
Caloric restriction (CR) might be effective for alleviating/preventing Alzheimer's disease (AD), but the biological mechanisms remain unclear. In the current study, we explored whether CR caused an alteration of gut microbiome and resulted in the attenuation of cognitive impairment of AD animal model.
Methods
Thirty‐week‐old male APP/PS1 transgenic mice were used as AD models (AD mouse). CR was achieved by 30% reduction of daily free feeding ( ad libitum , AL) amount. The mice were fed with CR protocol or AL protocol for six consecutive weeks.
Results
We found that with CR treatment, AD mice showed improved ability of learning and spatial memory, and lower levels of Aβ40, Aβ42, IL‐1β, TNF‐α, and ROS in the brain. By sequencing 16S rDNA, we found that CR treatment resulted in significant diversity in composition and abundance of gut flora. At the phylum level, Deferribacteres (0.04%), Patescibacteria (0.14%), Tenericutes (0.03%), and Verrucomicrobia (0.5%) were significantly decreased in CR‐treated AD mice; at the genus level, Dubosiella (10.04%), Faecalibaculum (0.04%), and Coriobacteriaceae UCG‐002 (0.01%) were significantly increased in CR‐treated AD mice by comparing with AL diet.
Conclusions
Our results demonstrate that the attenuation of AD following CR treatment in APP/PS1 mice may result from alterations in the gut microbiome. Thus, gut flora could be a new target for AD prevention and therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
- Guangdong Yunzhao Medical Technology Co., Ltd., Guangzhou, China.
- School of Basic Medical Sciences, Shenzhen University, Shenzhen, China.
ORCID-Profile: Ping Luan, Dong Zheng
Förderung
- Natural Science Foundation of Guangdong Province
- The Key Project of Basic Research of Shenzhen
Zitieren
APA
Chen, J., Zou, C., Guan, H., Zhou, X., Hou, L., Cui, Y., Xu, J., Luan, P., & Zheng, D. (2024). Caloric restriction leading to attenuation of experimental Alzheimer's disease results from alterations in gut microbiome. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14823
Vancouver
Chen J, Zou C, Guan H, Zhou X, Hou L, Cui Y, et al. Caloric restriction leading to attenuation of experimental Alzheimer's disease results from alterations in gut microbiome. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14823
BibTeX
@article{Chen2024,
author = {Chen, Junyu and Zou, Cong and Guan, Hongbing and Zhou, Xiaoming and Hou, Le and Cui, Yayong and Xu, Junhua and Luan, Ping and Zheng, Dong},
title = {Caloric restriction leading to attenuation of experimental Alzheimer's disease results from alterations in gut microbiome},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14823}
}
EUVIMED